We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01218516
Previous Study | Return to List | Next Study

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01218516
Recruitment Status : Completed
First Posted : October 11, 2010
Last Update Posted : June 20, 2016
Sponsor:
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2012
  Study Completion Date : November 2013
  Certification or Request for Extension to Delay Results Submission: June 25, 2015